Peter Maslak, MD

Chief, Hematology Laboratory Service

Peter Maslak, MD -- Chief, Hematology Laboratory Service

I joined the faculty at Memorial Sloan-Kettering as a hematologist in 1991, and just over a decade later took on the responsibility of Chief of the Hematology Laboratory Service. In this role, as well as in my capacity as Director of the Evelyn H. Lauder Breast Center and Associate Director of the Rockefeller Outpatient Pavilion, I am in charge of the laboratory tests done on our patients with blood-related (hematologic) diseases.

Over the years I have been involved in more than 20 clinical research trials to further refine and hone our approach to treating hematologic diseases such as leukemia and myelodysplastic syndrome (MDS). Based on these data, I have, in collaboration with my colleagues, published more than 170 journal articles, book chapters, and abstracts.

more…

Among our current research projects is an attempt to find new therapies for acute and chronic leukemia that harness the power of the immune system. We are also making advances in finding new ways to measure certain characteristics of cells in blood-related cancers and other malignancies through a measurement test called flow cytometric assays. I hope also to develop cell markers in the laboratory that can help us advance our clinical research.

Over the years it has also been very edifying, and gratifying, to be active on a national and international level in many of my specialty’s organizations, such as the American Association for Cancer Research, the American Society of Clinical Oncology, and the American Society of Hematology. In 2010 I was invited to be an Oversees Fellow for the Royal Society of Medicine (UK).

Location

New York City

Phone

212-639-5518

Clinical Expertise

Acute and Chronic Leukemias; Hematology; Autologous Stem Cell Transplantation; Myelodysplasia; Flow Cytometry

Languages Spoken

English

Education

MD, Mount Sinai School of Medicine

Residencies

University of Michigan Medical Center; Memorial Sloan-Kettering Cancer Center

Fellowships

Memorial Sloan-Kettering Cancer Center

Board Certifications

Internal Medicine; Medical Oncology; Hematology

Clinical Trials Led by Peter Maslak

A Phase II Trial of a WT-1 Vaccine in Patients with Acute Myeloid Leukemia

See My Colleagues in:

Publications by Peter Maslak

Visit PubMed for full listing of Peter Maslak journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

acute (uh-KYOOT)

Symptoms or signs that begin and worsen quickly; not chronic.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

autologous (aw-TAH-luh-gus)

Taken from an individual's own tissues, cells, or DNA.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

breast (brest)

Glandular organ located on the chest. The breast is made up of connective tissue, fat, and breast tissue that contains the glands that can make milk. Also called mammary gland.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

cancer (KAN-ser)

A term for diseases in which abnormal cells divide without control and can invade nearby tissues. Cancer cells can also spread to other parts of the body through the blood and lymph systems. There are several main types of cancer. Carcinoma is a cancer that begins in the skin or in tissues that line or cover internal organs. Sarcoma is a cancer that begins in bone, cartilage, fat, muscle, blood vessels, or other connective or supportive tissue. Leukemia is a cancer that starts in blood-forming tissue such as the bone marrow, and causes large numbers of abnormal blood cells to be produced and enter the blood. Lymphoma and multiple myeloma are cancers that begin in the cells of the immune system. Central nervous system cancers are cancers that begin in the tissues of the brain and spinal cord. Also called malignancy.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

cell (sel)

The individual unit that makes up the tissues of the body. All living things are made up of one or more cells.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

chronic (KRAH-nik)

A disease or condition that persists or progresses over a long period of time.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

clinical (KLIH-nih-kul)

Having to do with the examination and treatment of patients.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

flow cytometry (floh sy-TAH-meh-tree)

A method of measuring the number of cells in a sample, the percentage of live cells in a sample, and certain characteristics of cells, such as size, shape, and the presence of tumor markers on the cell surface. The cells are stained with a light-sensitive dye, placed in a fluid, and passed in a stream before a laser or other type of light. The measurements are based on how the light-sensitive dye reacts to the light.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

hematologist (HEE-muh-TAH-loh-jist)

A doctor who specializes in treating blood disorders.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

immune system (ih-MYOON SIS-tem)

The complex group of organs and cells that defends the body against infections and other diseases.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

leukemia (loo-KEE-mee-uh)

Cancer that starts in blood-forming tissue such as the bone marrow and causes large numbers of blood cells to be produced and enter the bloodstream.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

medicine (MEH-dih-sin)

Refers to the practices and procedures used for the prevention, treatment, or relief of symptoms of a diseases or abnormal conditions. This term may also refer to a legal drug used for the same purpose.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

National Institutes of Health (NA-shuh-nul IN-stih-TOOTS … helth)

A federal agency in the U.S. that conducts biomedical research in its own laboratories; supports the research of non-Federal scientists in universities, medical schools, hospitals, and research institutions throughout the country and abroad; helps in the training of research investigators; and fosters communication of medical information. Access the National Institutes of Health Web site at . Also called NIH.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

outpatient (OWT-pay-shunt)

A patient who visits a health care facility for diagnosis or treatment without spending the night. Sometimes called a day patient.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

stem cell (stem sel)

A cell from which other types of cells develop. For example, blood cells develop from blood-forming stem cells.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

syndrome (SIN-drome)

A set of symptoms or conditions that occur together and suggest the presence of a certain disease or an increased chance of developing the disease.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

Making an Appointment

We will assist you or your referring doctor to make an appointment with one of our physicians.